✦ LIBER ✦

6-Thioguanine therapy in Crohn′s disease—Observational data in Swedish patients

✍ Scribed by S.H.C. Almer; H. Hjortswang; U. Hindorf

Book ID: 119229270
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 199 KB
Volume: 41
Category: Article
ISSN: 1590-8658
DOI: 10.1016/j.dld.2008.07.314

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ECCO consensus: Evidence-based use of 6-

ECCO consensus: Evidence-based use of 6-thioguanine therapy in Crohn's disease?

✍ Nanne K.H. de Boer; Dirk P. van Asseldonk; Adriaan van Bodegraven 📂 Article 📅 2010 🏛 Oxford University Press 🌐 English ⚖ 144 KB

6-Thioguanine maintains remission in chr

6-Thioguanine maintains remission in chronic active Crohn's disease

✍ Herrlinger, Klaus R.; Kreisel, Wolfgang; Deibert, Peter; Schwab, Matthias; Felle 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 266 KB

Further experience with the use of 6-thi

Further experience with the use of 6-thioguanine in patients with Crohn's disease

✍ Azhar Ansari; Tim Elliott; Farina Fong; Monica Arenas-Hernandez; Giles Rottenber 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

Background: 6-Thioguanine (6-TG) is efficacious in patients with Crohn's Disease (CD) failing conventional immunosuppression but there are reports of hepatotoxicity. We report our experience of the safety and efficacy of 6-TG in a series of patients with CD. Methods: A retrospective study of patien

High variation of 6-thioguanine absorpti

High variation of 6-thioguanine absorption in patients with chronic active Crohn's disease

✍ Deibert, Peter; Dilger, Karin; Hofmann, Ute; Nauck, Susanne; Stoelben, Susanne; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 495 KB

Safe 6-thioguanine therapy of a TPMT def

Safe 6-thioguanine therapy of a TPMT deficient Crohn's disease patient by using therapeutic drug monitoring

✍ W.G.N. Mares; D.R. Wong; L.P.L. Gilissen; A.A.M. Masclee; P.M. Hooymans; L.G.J.B 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 131 KB

An open-label pilot study using thioguan

An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy

✍ Dr. Marla C. Dubinsky; Philip V. Hassard; Dr. Ernest G. Seidman; Lori Y. Kam; Ma 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 272 KB